As economists, governments, policymakers and medical experts build cost benefit models to decide when it’s safe to reopen the economy, consumers are doing their own cost benefit analyses. The decision to get back to their once normal routines will depend upon whether consumers believe the benefit of the degraded experience that awaits them in a partially reopened economy outweighs the cost of the health risk they face if they do. Based on the latest PYMNTS research of nearly 12,000 U.S. consumers, many are likely to sit it out. For now. Maybe even for the rest of this year. …see more